Related Articles
Two postoperative chemotherapies for gastric cancer: FOLFOX4 vs. TPF
Comparison of adjuvant FOLFOX4 chemotherapy and oral UFUR/LV following adjuvant FOLFOX4 chemotherapy in patients with stage III colon cancer subsequent to radical resection
Effect of celecoxib plus standard chemotherapy on serum levels of vascular endothelial growth factor and cyclooxygenase‑2 in patients with gastric cancer
Comparative analysis of the efficacy and safety of modified FOLFOX-6 and DCF regimens as first-line treatment in advanced gastric cancer
Lack of association between expression of MRP2 and early relapse of colorectal cancer in patients receiving FOLFOX‑4 chemotherapy